Abdominal Neoplasms - 350 Studies Found

Completed : Comparison of Hemodynamics Between Dexmedetomidine and Propofol for Sedation in Patients With Abdominal Surgery
:
  • Disorder; Mental, Sedative
  • Pain, Postoperative
  • Surgery : 2014-10-27
    :
    • Drug: Propofol Sedation

Not yet recruiting : EDMONd - Elemental Diet in Bowel Obstruction
:
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Ovarian Disease
  • : 2017-04-03
    : Dietary Supplement: Elemental 028 Extra Liquid A nutritionally complete, liquid elemental diet consistin
Completed : Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery
:
  • Malignant Gastrointestinal Neoplasm
  • Malignant Peritoneal Neoplasm

: 2015-01-29
:
  • Device: Management of Therapy Complications Fitbit Zip (portable pedometer d
Active, not recruiting : Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
:
  • Fallopian Tube
  • Primary Peritoneal Cancer
  • Solid Tumors (e.g
    : 2011-04-04
    : Drug: ABT-767 ABT-767 once or twice daily for a 28 day cycle
Completed : Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
:
  • Prostatic Neoplasm
  • Genital Neoplasms, Male
  • Neoplasms, Abdo
    : 2011-03-14
    : Drug: STI571 (Glivec®) Other Name: Glivec
Withdrawn : A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
: Ovarian, Fallopian Tube and Peritoneal Cancer
: 2014-10-27
:
  • Biological: Vaccine--‐primed, CD3/CD28--‐costimulated autologous
Recruiting : AZD1775 Plus Chemotherapy in Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
: 2014-10-14
:
  • Drug: AZD1775 + carboplatin AZ
Recruiting : "Re-Stimulated" Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: Recurrent, Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: 2013-06-11
:
  • Biological: Re-stimulated tumor-infiltrating lymphocytes (TILs)

Terminated : Abraxane/Bevacizumab
:
  • Ovarian Cancer
  • Peritoneal Cancer

: 2013-03-27
:
  • Drug: Abraxane Abraxane will b
Recruiting : An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)
: Peritoneal Neoplasms
: 2012-09-28
<<< Previous | Next >>>